Key facts
- This page summarizes Jack Bendheim's Form 4 filing for PHIBRO ANIMAL HEALTH CORP (PAHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2026, 16:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
Footnote F2
The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F3
The reported securities are directly held by Jack Bendheim.
Footnote F4
The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.